SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-18-011784
Filing Date
2018-08-27
Accepted
2018-08-27 16:05:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0818holubiak_citius.htm SC 13D 40671
  Complete submission text file 0001213900-18-011784.txt   42138
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 63 GREAT ROAD MAYNARD MA 01754
Business Address
HOLUBIAK MYRON Z (Filed by) CIK: 0001199080 (see all company filings)

Type: SC 13D

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Subject) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-90253 | Film No.: 181039035
SIC: 2834 Pharmaceutical Preparations